Bystander monocytic cells drive infection-independent NLRP3 inflammasome response to SARS-CoV-2

Inflammasome activation is associated with severe COVID-19. The impact of inflammasome activation on viral replication and mechanistic details of this activation are not clarified. This study advances our understanding of the role of inflammasome activation in macrophages by identifying TLR2, NLRP3, ASC, and caspase-1 as dependent factors in this activation. Further, it highlights that SARS-CoV-2 inflammasome activation is not a feature of nasal epithelial cells but rather activation of bystander macrophages in the airway. Finally, we demonstrate that two pro inflammatory cytokines produced by inflammasome activation, IL-18 and IL-1β, do not restrict viral replication and are potential targets to ameliorate pathological inflammation in severe COVID-19.

Authors

Institutions

Publication Details

Journal
mBio
Published
2024-09-06
DOI
https://doi.org/10.1128/mbio.00810-24
Citations
5
Primary Topic
Inflammasome and immune disorders
Type
article
Field-Weighted Citation Impact
1.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bystander monocytic cells drive infection-independent NLRP3 inflammasome response to SARS-CoV-2

Petros C. Karakousis, Guido Massaccesi, Eduardo Anaya, Alvaro A. Ordoñez et al.
5 citations
mBio
Inflammasome and immune disorders
1.17
article

Bystander monocytic cells drive infection-independent NLRP3 inflammasome response to SARS-CoV-2

Petros C. Karakousis, Guido Massaccesi, Eduardo Anaya, Alvaro A. Ordoñez, Leon L. Hsieh, Franco R. D’Alessio, Alexis Figueroa, Victor R. DeFilippis, Monika M. Looney, Andrew Pekosz, Andrew H. Karaba, Georgia Stavrakis, Andrea L. Cox
article en
5 citations

Abstract

Inflammasome activation is associated with severe COVID-19. The impact of inflammasome activation on viral replication and mechanistic details of this activation are not clarified. This study advances our understanding of the role of inflammasome activation in macrophages by identifying TLR2, NLRP3, ASC, and caspase-1 as dependent factors in this activation. Further, it highlights that SARS-CoV-2 inflammasome activation is not a feature of nasal epithelial cells but rather activation of bystander macrophages in the airway. Finally, we demonstrate that two pro inflammatory cytokines produced by inflammasome activation, IL-18 and IL-1β, do not restrict viral replication and are potential targets to ameliorate pathological inflammation in severe COVID-19.

mBioVol. 15(10)
Johns Hopkins University (US), Oregon Health & Science University (US), Johns Hopkins Medicine (US)
Bill and Melinda Gates Foundation, Johns Hopkins University, National Institutes of Health, Health Resources and Services Administration, National Cancer Institute, National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 22%
Inflammasome and immune disorders
1.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.